Famotidine in Schizophrenia

NCT01946295 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

140

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Famotidine
DRUG: Placebo

Sponsor

Jesper Ekelund

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]